Naveen Pemmaraju

Naveen Pemmaraju

UNVERIFIED PROFILE

Are you Naveen Pemmaraju?   Register this Author

Register author
Naveen Pemmaraju

Naveen Pemmaraju

Publications by authors named "Naveen Pemmaraju"

Are you Naveen Pemmaraju?   Register this Author

100Publications

3160Reads

5Profile Views

Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm.

Expert Rev Clin Pharmacol 2019 Oct 1;12(10):941-946. Epub 2019 Oct 1.

Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2019.1662297DOI Listing
October 2019

Sudden blastic transformation in treatment-free remission chronic myeloid leukaemia.

Br J Haematol 2019 Oct 4. Epub 2019 Oct 4.

Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16245DOI Listing
October 2019

Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report.

Hematol Oncol Stem Cell Ther 2019 Sep 16;12(3):161-165. Epub 2017 Aug 16.

Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S16583876173009
Publisher Site
http://dx.doi.org/10.1016/j.hemonc.2017.07.004DOI Listing
September 2019

Topoisomerase II inhibitors in AML: past, present, and future.

Expert Opin Pharmacother 2019 Sep 28;20(13):1637-1644. Epub 2019 May 28.

Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14656566.2019.1
Publisher Site
http://dx.doi.org/10.1080/14656566.2019.1621292DOI Listing
September 2019

First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL).

Leuk Lymphoma 2019 Sep 30:1-5. Epub 2019 Sep 30.

Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1660967DOI Listing
September 2019

Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm.

Ther Adv Hematol 2019 23;10:2040620719874733. Epub 2019 Sep 23.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719874733DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759709PMC
September 2019

Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors.

Curr Hematol Malig Rep 2019 Aug 1. Epub 2019 Aug 1.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-019-00538-4
Publisher Site
http://dx.doi.org/10.1007/s11899-019-00538-4DOI Listing
August 2019

gastroenteritis in a patient with chronic lymphocytic leukemia.

Leuk Lymphoma 2019 Jul 15:1-2. Epub 2019 Jul 15.

a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1639171DOI Listing
July 2019

Ibrutinib and Venetoclax for First-Line Treatment of CLL.

N Engl J Med 2019 05;380(22):2095-2103

From the Departments of Leukemia (N.J., M. Keating, P.T., A.F., J.B., G.B., K.T., Z.E., T.K., M. Konopleva, Y.A., M.Y., C.D., P.B., M.O., N.P., E.J., K. Sasaki, K. Sondermann, N.C., C.W., A.A., H.K., W.W.), Lymphoma and Myeloma (N.F.), Hematopathology (R.K.-S., K.P., J.J.), Diagnostic Radiology (N.G.), Biostatistics (X.W.), and Experimental Therapeutics (W.P., V.G.), University of Texas M.D. Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1900574DOI Listing
May 2019

SMAC mimetics as potential cancer therapeutics in myeloid malignancies.

Br J Haematol 2019 Apr 5;185(2):219-231. Epub 2019 Mar 5.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15829DOI Listing
April 2019

Patient with mixed-phenotype acute leukemia with CBFB rearrangement.

Leuk Lymphoma 2019 Apr 23:1-3. Epub 2019 Apr 23.

a Departement of Leukemia , University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1605069DOI Listing
April 2019

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.

N Engl J Med 2019 04;380(17):1628-1637

From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1815105DOI Listing
April 2019

Treatment advances in blastic plasmacytoid dendritic cell neoplasm.

Authors:
Naveen Pemmaraju

Clin Adv Hematol Oncol 2019 04;17(4):207-209

The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
April 2019

Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation.

J Clin Pathol 2019 Mar 22;72(3):251-257. Epub 2018 Nov 22.

Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2018-205399DOI Listing
March 2019

More on Blastic Plasmacytoid Dendritic-Cell Neoplasms.

N Engl J Med 2019 02;380(7):695-6

Dana–Farber Cancer Institute, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1814963DOI Listing
February 2019

Systemic Immunotherapy Effective for Refractory Extramedullary Acute Myeloid Leukemia.

JCO Precis Oncol 2019 6;3. Epub 2019 Feb 6.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.18.00198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448807PMC
February 2019

The co-occurrence of driver mutations in chronic myeloproliferative neoplasms.

Ann Hematol 2018 Nov 27;97(11):2071-2080. Epub 2018 Jun 27.

Department of Leukemia, UT MD Anderson Cancer Center, 1515 Holcombe Blvd (Unit 428), Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-018-3402-x
Publisher Site
http://dx.doi.org/10.1007/s00277-018-3402-xDOI Listing
November 2018

Prognostic significance of hyperdiploidy in adult acute myeloid leukemia.

Am J Hematol 2018 11 9;93(11):E357-E360. Epub 2018 Sep 9.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25240DOI Listing
November 2018

Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm.

Leuk Res 2018 10 24;73:21-23. Epub 2018 Aug 24.

Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.08.014DOI Listing
October 2018

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.

J Clin Oncol 2018 06 27;36(18):1788-1797. Epub 2018 Apr 27.

Kiyomi Morita, Hagop M. Kantarjian, Feng Wang, Yuanqing Yan, Carlos Bueso-Ramos, Koji Sasaki, Ghayas C. Issa, Sa Wang, Jeffrey Jorgensen, Xingzhi Song, Jianhua Zhang, Samantha Tippen, Rebecca Thornton, Marcus Coyle, Latasha Little, Curtis Gumbs, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Jorge E. Cortes, Tapan Kadia, Elias Jabbour, Guillermo Garcia-Manero, Keyur P. Patel, P. Andrew Futreal, and Koichi Takahash, The University of Texas MD Anderson Cancer Center, Houston, TX; Kiyomi Morita, The University of Tokyo, Tokyo; and Koichi Takahashi, Kyoto University, Kyoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.6757DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008108PMC
June 2018

L-carnitine and Vitamin B Complex for the Treatment of Pegasparaginase-induced Hyperbilirubinemia.

Clin Lymphoma Myeloma Leuk 2018 05 26;18(5):e191-e195. Epub 2018 Feb 26.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.02.014DOI Listing
May 2018

Time to response and survival in hypomethylating agent-treated acute myeloid leukemia.

Leuk Lymphoma 2018 04 25;59(4):1012-1015. Epub 2017 Aug 25.

a Department of Leukemia , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1365857DOI Listing
April 2018

Ocular extramedullary myeloid leukaemia.

Br J Haematol 2018 03 23;180(5):738-740. Epub 2016 Nov 23.

Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14430DOI Listing
March 2018

Erythroleukemia-historical perspectives and recent advances in diagnosis and management.

Blood Rev 2018 03 18;32(2):96-105. Epub 2017 Sep 18.

Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2017.09.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857409PMC
March 2018

8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms.

Leuk Res 2018 03 3;66:73-78. Epub 2018 Feb 3.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.01.013DOI Listing
March 2018

Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.

Ann Hematol 2018 Jan 15;97(1):109-121. Epub 2017 Nov 15.

Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, 1400 Holcombe Blvd, Unit 428, PO Box 301439, Houston, TX, 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3165-9DOI Listing
January 2018

Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.

J Neurooncol 2018 Jan 1;136(2):223-231. Epub 2017 Dec 1.

Department of Leukemia, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2676-5DOI Listing
January 2018

Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond.

Authors:
Naveen Pemmaraju

Curr Hematol Malig Rep 2017 12;12(6):510-512

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Unit 428, PO BOX 301402, Houston, TX, 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-017-0425-7DOI Listing
December 2017

Editorial overview: Emerging importance of social media for real-time communication in the modern medical era.

Authors:
Naveen Pemmaraju

Semin Hematol 2017 10 25;54(4):175-176. Epub 2017 Aug 25.

Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2017.08.005DOI Listing
October 2017

The use and impact of Twitter at medical conferences: Best practices and Twitter etiquette.

Semin Hematol 2017 10 24;54(4):184-188. Epub 2017 Aug 24.

Aurora Research Institute, Aurora Health Care, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2017.08.003DOI Listing
October 2017

Disease-specific hashtags and the creation of Twitter medical communities in hematology and oncology.

Semin Hematol 2017 10 30;54(4):189-192. Epub 2017 Aug 30.

Department of Stem Cell Transplant, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: https://twitter.com/Transplant_Doc.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2017.08.004DOI Listing
October 2017

Questions on asparaginase-associated pancreatitis.

Lancet Oncol 2017 09;18(9):1148-1149

Department of Leukemia, University of Texas, MD Anderson Cancer Center, Unit 428, PO Box 301439, Houston, TX 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30610-1DOI Listing
September 2017

Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.

Leuk Res 2017 08 2;59:110-116. Epub 2017 Jun 2.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573611PMC
August 2017

Analysis of the Use and Impact of Twitter During American Society of Clinical Oncology Annual Meetings From 2011 to 2016: Focus on Advanced Metrics and User Trends.

J Oncol Pract 2017 07 17;13(7):e623-e631. Epub 2017 May 17.

The University of Texas MD Anderson Cancer Center, Houston, TX; Aurora Research Institute, Aurora Health Care, Milwaukee, WI; Mayo Clinic, Scottsdale AZ; US Department of Veterans Affairs; and Nephrology On-Demand Analytics, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.021634DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508448PMC
July 2017

Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevance.

Leuk Res 2017 06 8;57:85-88. Epub 2017 Mar 8.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.03.006DOI Listing
June 2017

PET-positive lymphadenopathy in CLL-Not always Richter transformation.

Am J Hematol 2017 04 7;92(4):405-406. Epub 2017 Feb 7.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352509PMC
April 2017

Mixed angioinvasive exserohilum and scedosporium infection in a patient with AML.

Am J Hematol 2017 Jan 14;92(1):119-120. Epub 2016 Jul 14.

Departments of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24455DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884637PMC
January 2017

Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Curr Hematol Malig Rep 2016 12;11(6):462-467

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-016-0340-3DOI Listing
December 2016